Navigation Links
Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial

nd a broader range of activity than macrolides against Gram-positive bacteria associated with respiratory tract infections, and, again in in vitro tests, it appears to be effective against penicillin- and macrolide-resistant bacteria. Cethromycin has a mechanism of action that may slow the onset of future bacterial resistance. In addition to its utility in CAP, cethromycin has also been shown to be effective in animal studies for the prophylactic treatment of inhalation anthrax post exposure. The FDA has designated cethromycin as an orphan drug for the prophylactic treatment of inhalation anthrax post exposure, but the FDA has not yet approved the drug for marketing in this or any other indication.

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and inflammation. The Company's lead candidate, cethromycin, is a novel once-a-day antibiotic in late-stage clinical development for the treatment of respiratory tract infections including CAP. For more information, please visit us on the web at http://www.advancedlifesciences.com.

Forward-Looking Statements

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to technology and product development, clinical trials, market acceptance, government regulation and regulatory approval processes, intellectual property rights and litigation, dependence on collaborative relationshi
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
2. Cethromycin Shown Effective Against Anthrax in Study
3. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
4. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. Addex Achieves Statistically Significant Outcome in Phase IIa Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease
7. Vicals Vaxfectin Adjuvant Achieves Dose-Sparing Effect With Seasonal Influenza Vaccine
8. Mymetics HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
9. Integrated Biopharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
11. ENDEAVOR IV Clinical Trial Meets Primary Endpoint

Post Your Comments:
(Date:11/25/2009)...PARK, Md., Nov. 25 Reme...ving cream-like foam that stops severe bleeding, w...ecurity Idea category of the Global Security Chall... Selected from more than 100 entries from around t...at the GSC Security Summit conference held at the ...
(Date:11/25/2009)...ARBIN, China, Nov. 25 /PRNewswire-Asia-FirstCall/ ...ical" or "the Company") (Nasdaq: CSKI ), a,leadin...ng and producing,over-the-counter drugs in the Peo...hat the Company recently passed the Chinese Nation... Biological Products ("ICPBP") examination,for two...
(Date:11/25/2009)... Calif., Nov. 25 Abaxis,... manufacturing point-of-care blood analysis system...nd chief executive officer, will present at the 21...Wednesday, December 2, 2009 at 2:00 p.m. ET. The c...l in New York City. ,, About Abaxis ,, Ab...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Miller McCune Magazine Wins Environmental Journalism Prize 52565 1Miller McCune Magazine Wins Environmental Journalism Prize 52565 2Molecule Helps Leukemia Cells Hide From Immune System 52561 1Molecule Helps Leukemia Cells Hide From Immune System 52561 2National Science Foundation Announces 2420M Research Award to South Carolina 52556 1National Science Foundation Announces 2420M Research Award to South Carolina 52556 2National Science Foundation Announces 2420M Research Award to South Carolina 52556 3
...tudy to support Urgent(R) PC clinical success and ...Jan. 26 Uroplasty, Inc. (Amex: UPI ) announced ...randomized, controlled multicenter clinical study ...eatment of overactive bladder (OAB) symptoms of ur...urinary voids. A total of 214 patients have enrol...
...80 Patient Trial of 2nd Generation Oxazolidinone E...ius Therapeutics, Inc. today announced the complet...Phase 2 clinical trial testing the oral dosage for...with complicated skin and skin structure infection...linical sites in the United States, examined the e...
Other Medicine Technology:Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule 2Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule 3Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule 4Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections 2
(Date:11/26/2009)...ybdate (TM) has been shown in studies to be effect...caused by an overload of copper, and certain metas...wever, is known about how the drug works at the mo... University researchers now has provided an invalu...ound to copper-loaded metallochaperones. The drug ...
(Date:11/26/2009)...al rollercoaster, study finds , , THURSD...actor meets the jubilant sports fan. , A new st...ho root for the winning team -- enjoy the greatest...d victory was in doubt, producing feelings of worr...iving weekend as you,re glued to the TV set, watch...
(Date:11/26/2009)...the Live Life Again Center, a practice offering w... number of physicians who are taking advantage of...ndividuals who are interested in surgical weight l...utilizing Facebook to share before-and-after photo...unity. , Dallas, TX (Vocu...
(Date:11/26/2009)...ions announces a highly effective and unconvention... to make an economic recovery. , ...the type of challenge that could send ailing holid...avid Benton, business growth expert and author of ... The Rfactor Intensive . “Fear is one of t...
(Date:11/25/2009)...re-USNewswire/ -- When most people hear the acrony...actor can also give patients the help they need. T... is where your jaw (mandible) contacts/connects wi...mon symptoms associated with TMJ dysfunction are p... But many other symptoms can be caused from TMJ dy...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
..., Pa., Feb. 11 The Office of,Administration today... to,March 21 for retired state employees to select...ective on May 1., "We understand choosing a healt...ry of Administration Naomi Wyatt said.,"Therefore,...
...GE, Mass.--A new thin-film coating developed at MI...rgets in the body following implantation, essentia... eventually be used to deliver drugs for cancer, e..., You can mete out what is needed, exactly when i...
...1 million, Five-year Grant, from New York State De...ntamination before Child Becomes Lead,Poisoned, N... Prevention Program at The Children,s Hospital at ...ren and,pregnant women with elevated blood lead le...
...d to hundreds of allergic reactions and possibly 4...lthDay News) -- Baxter HealthCare Corp., which pro...e United States, said Monday that it was temporari...s. , The cause of the allergic reactions isn,t kno...
..., Fla., Feb. 11 Lincare Holdings,Inc. (Nasdaq: L...iratory,therapy services delivered to patients in ...e fourth quarter and year ended December 31, 2007....06. The Company estimates that the increase in net...
...olled hypertension rates in men and women vary acr... south and including the nations capital should b...eport in Circulation: Journal of the American Hear...mination clinic (MEC) and averaged. The first mea...
Other Medicine News:Health News:Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21 2Health News:MIT develops thin-film 'micro pharmacy' 2Health News:Montefiore Lead Poisoning Prevention ProgramNamed One of Three State Regional Resource Centers 2Health News:Manufacturer Halts Production of Blood Thinner Heparin 2Health News:Manufacturer Halts Production of Blood Thinner Heparin 3Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 2Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 3Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 4Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 5Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 6Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 7Health News:High blood pressure worsening in all states for women; begins to stagnate for men 2Health News:High blood pressure worsening in all states for women; begins to stagnate for men 3
Carpentier-McCarthy-Adams IMR ETlogix Annuloplasty Ring
MediSoft Patient Accounting Software New Version 9
DCR Set, Straight
...ainer of the Robot Stainer HMS 760 X is equipped w...d and transferred during program execution. This f...venting system contributes to a significant reduct...n acrylic glass cover and a vapor escape via filte...
Medicine Products: